Early selegiline therapy reduces levodopa dose requirement in Parkinson's disease.

MLA

Myllylä, V. V., et al. “Early Selegiline Therapy Reduces Levodopa Dose Requirement in Parkinson’s Disease.” Acta Neurologica Scandinavica, vol. 91, no. 3, Mar. 1995, pp. 177–82. EBSCOhost, https://doi.org/10.1111/j.1600-0404.1995.tb00429.x.

APA

Myllylä, V. V., Heinonen, E. H., Vuorinen, J. A., Kilkku, O. I., & Sotaniemi, K. A. (1995). Early selegiline therapy reduces levodopa dose requirement in Parkinson’s disease. Acta Neurologica Scandinavica, 91(3), 177–182. https://doi.org/10.1111/j.1600-0404.1995.tb00429.x

Chicago

Myllylä, V. V., E. H. Heinonen, J. A. Vuorinen, O.I. Kilkku, and K. A. Sotaniemi. 1995. “Early Selegiline Therapy Reduces Levodopa Dose Requirement in Parkinson’s Disease.” Acta Neurologica Scandinavica 91 (3): 177–82. doi:10.1111/j.1600-0404.1995.tb00429.x.